Please assess the completion status of the following clinical trial:

Trial Title: Evaluation Of The Portal Pressure By Doppler Ultrasound In Cirrhotic Patients Before And After Simvastatin

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Positive diagnosis of cirrhosis by US (coarse echogenic pattern, bulky caudate lobe, attenuated hepatic veins)~* Clinical manifestations of portal hypertension (as esophageal varices ,splenomegaly, ascites and encephalopathy grade I-II)~Exclusion Criteria:~* Pregnancy~* Hepatic encephalopathy grade III-IV~* Hepatocellular carcinoma~* Treatment with statins in the previous 3 months~* Hypersensitivity to statins~* Previous surgical shunt or TIPS~* Treatment with calcium channel blockers

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Simvastatin (Type: ACTIVE_COMPARATOR): Simvastatin 20 mg/day for two weeks (increased to 40 mg/day at day 15) for another two weeks
- no treatment (Type: NO_INTERVENTION): no treatment

Based on this trial design, predict the completion outcome and termination type (if applicable).